BRIEF — Saniona Says Data Reinforce SAN2465's Potential

Oct 13 (Reuters) — Saniona AB: Announces New Preclinical Data Reinforcing San2465's Potential As A Rapid-acting Antidepressant Preparing Investigational New Drug (Ind) Application To U.s. Food And Drug Administration, Expected To Be Submitted By End Of October San2465 Significantly Enhanced Hippocampal Synaptic Plasticity In Preclinical Studies Source text:... Further company coverage: SANION.ST (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;)